Poor AstraZeneca. The Scottish Medicines Consortium has rejected its esomeprazole (Nexium) for use in Scotland following two separate assessments.
The first assessment concluded that esomeprazole is not recommended for the healing of gastric ulcers associated with non-steroidal anti-inflammatory drug (NSAID) therapy.
The second assessment concluded that esomeprazole is not recommended for the prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory (NSAID) therapy in patients at risk.
Funny, given AZ's past Scottish links!
Source: Prescribing Advice for GPs
No comments:
Post a Comment